Expression and bioactivity identification of soluble MG7 scFv

World Journal of Gastroenterology

Volumn 8, Issue 1, 2002, Pages 99-102

  Yu, Zhao Cai ^a   Ding, Jie ^a   Pan, Bo Rong ^a   Fan, Dai Ming ^a   Zhang, Xue Yong ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MG7; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE; UNCLASSIFIED DRUG;

ANTIBODY LIBRARY; ANTIGEN BINDING; ARTICLE; ASSAY; BACTERIOPHAGE; BINDING AFFINITY; CLONE; CONTROLLED STUDY; DNA SEQUENCE; DRUG TARGETING; ENZYMATIC DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GENE; GENE ISOLATION; GENE THERAPY; GENETIC TRANSFECTION; GENOME SIZE; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; OSMOTIC STRESS; PLASMID; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEQUENCE ANALYSIS; STOMACH CANCER; WESTERN BLOTTING;

EID: 0036171753     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v8.i1.99     Document Type: Article

References (70)

1. Clinicopathological analysis of patients with gastric cancer in 1200 cases
2. Selection of human anti-HAV McAb from a phage antibody library
3. Effect of chemotherapy or targeting chemotherapy on apoptosis of colorectal carcinoma
4. Induction of apoptosis in human gastric carcinoma cell line SGC7901 by anti-Fas monoclonal antibody
5. Research and progress is in vivo gene therapy for primary liver cancer
6. Transduction efficiency, biologic effect and mechanism of recombinant RA538, antisense C-myc adenovirus on different cell lines
7. Experimental study on the treatment of gastric cancer by TK gene combined with mIL-2 gene
8. Killing effect of tetracycline-controlled expression of DT/VEGF system on liver cell cancer
9. Gene therapy for pancreatic neoplasms
10. Tetracycline controlled DT/VEGF system gene therapy mediated by adenovirus vector
11. Current situation in studies of gene therapy for liver cirrhosis and liver fibrosis
12. Killing effect of DT/VEGF system on gastric carcinoma cell
13. Gene therapy for human colorectal carcinoma using promoter controlled bacterial ADP-ribosylating toxin genes human CEA, PEA and DTA gene transfer
14. Anti-CEA monoclonal antibody targeting therapy for colorectal carcinoma
15. Targeting human T cells by retroviral vectors displaying antibody domains selected from a phage display library
16. Experimental and clinical study on targeting treatment of liver cancer using radionuclide- anti-AFP antibody -MMC doubllet
17. Construction and expression of mouse/humanized ScFv and their fusion to humanized mutant TNF ( against hepatocellular carcinoma
18. Recent progress in anti-hepatoma monoclonal antibody and its application
19. Modification of an adenoviral vector with biologically selected peptides: A novel strategy for gene delivery to cells to choice
20. Antineoplastic effect of intracellular expression of a single-chain antibody directed against type IV collagenase
21. Construction and expression of ScFv from anti-human gastric cancer McAb 3H11
22. Killing effect of TNF-related apoptosis inducing ligand regulated by tetracycline on gastric cancer cell line NC1-N87
23. Construction of eukaryotic expression vector of sense and antisense VEGF165 and its expression regulation
24. Anti-tumor activity of defensin on gastric cancer cell line in vitro
25. Construction of sense and antisense hTR eukaryotic expression vector
26. Apoptosis in human colorectal cancer Lovo cells induced by HSVtK/GCV system in vitro
27. Herpes simplex virus thymidine kinase/ganciclovir system combined with 5-FU for the treatment of experimental colorectal cancer
28. The antisense gene of growth factor receptor reversing the malignant phenotype of human hepatoma cells
29. Reduction of tumorigenicity of SMMC-7721 hepatoma cells by vascular endothelial growth factor antisense gene therapy
30. Preparation and immunohistologic identification of mAbs against a poor differentiated gastric cancer line MKN-46-9
31. Human anti-CD30 recombinant antibodies by guided phage antibody selection using cell panning
32. Introduction to antibody engineering and phage display
33. Human recombinant single-chain antibody fragments, specific for the hypervariable region 1 of hepatitis C virus, from immune phage-display libraries
34. Selection of recombinant antibodies specific for pathogenic Streptococcus suis by subtractive phage display
35. Construction and characterization of a novel recombinant single-chain variable fragment antibody against Western equine encephalitis virus
36. In vivo selection of ScFv from phage display libraries
37. Phage-display library selection of high-affinity human single-chain antibodies to tumor-associated carbohydrate antigens sialyl Lewisx and Lewisx
38. Isolation of human tumor-specific antibodies by selection of an antibody phage library on melanoma cells
39. Functional expression in bacteria and plants of an ScFv antibody fragment against tospoviruses
40. Expression and characterization of anti-NCA-95 ScFv (CEA 79 ScFv) in a prokaryotic expression vector modified to contain a Sfi I and Not I site
41. Isolation and characterization of an anti-CD16 single-chain Fv fragment and construction of an anti-HER2/neu/anti-CD16 bispecific scFv that triggers CD16-dependent tumor cytolysis
42. Development of a hyperimmune anti-MUC-1 single chain antibody fragments phage display library for targeting breast cancer
43. Antibody production without animals
44. Isolation of human colorectal tumour reactive antibodies using phage display technology
45. Generating improved single-chain Fv molecules for tumor targeting
46. Phage antibodies against human dendritic cell subpopulations obtained by flow cytometry-based selection on freshly isolated cells
47. Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney
48. Preparation and activity of conjugate of monoclonal antibody HAb18 against hepatoma F (ab′) 2 fragment and staphylococcal enterotoxin A
49. Construction and expression of anti-HCC immunotoxin of sFv-TNF-( and GFP fusion proteins
50. Production of a single chain anti-CEA antibody from the hybridoma cell line T84.66 using a modified colony-lift selection procedure to detect antigen-positive ScFv bacterial clones
51. 7 mAb by phage display technology
52. The Hsp90 chaperone complex-A potential target for cancer therapy?
53. Antitumoral activity of low density lipoprotein aclacinomycin complex in mice bearing H22 tumor
54. A comparison between intravenous and peritoneal route on liver targeted uptake and expression of plasmid delivered by Glyco poly L-lysine
55. Lactosamination of liposomes and hepatotropic targeting research
56. Inhibitory effects of EGFR antisense oligodeoxynucleotide in human colorectal cancer cell line
57. Antihepatoma effect of alpha fetoprotein antisense phosphorothioate oligodeoxyribonucleotides in vitro and in mice
58. Comparison of gene expression between normal colon mucosa and colon carcinoma by means of messenger RNA differential display
59. Overexpression of P-glycoprotein in hepatocellular carcinoma and its clinical implication
60. Expression of IGF-II, p53, p21 and HBxAg in precancerous events of hepatocarcinogenesis induced by AFB1 and/or HBV in tree shrews
61. A preliminary study on ras protein expression in human esophageal cancer and precancerous lesions
62. Expression of VEGF121 in gastric carcinoma MGC803 cell line
63. The function of apoptosis and protein expression of bcl2, p53 and C-myc in the development of gastric cancer
64. Clinical evaluation of several tumor markers in the diagnosis of primary hepatic cancer
65. Immunohistochemical study on p53, Hrasp21, cerbB2 protein and PCNA expression in tumor tissues of Han and minority ethnic patients with primary hepatic carcinoma in Xinjiang
66. Expression of insulin like growth factor and its receptor in hepatocellular carcinogenesis
67. The prognostic value of preoperative serum levels of CEA, CA19 - 9 and CA72 - 4 in patients with colorectal cancer
68. Function of apoptosis and expression of the proteins Bcl-2, p53 and C-myc in the development of gastric cancer
69. Differential expression of a novel colorectal cancer differentiation-related gene in colorectal cancer
70. Tumoricidal activation of murine resident peritoneal macrophages on pancreatic carcinoma by interleukin2 and monoclonal antibodies